LDS/Medical Tests/Hereditary Hearing Loss Gene Panel

Hereditary Hearing Loss Gene Panel

Sensorineural hearing loss (SNHL)is one of the commonest inherited disorders and has impacts on both social and psychological development. Hearing impairment can be acquired before or after birth and may result from infection (e.g. CMV, Toxoplasmosis, Rubella, Zika, syphilis), and malformations, of the middle or inner ear. Hereditary causes have an incidence of 1-2 per 1000 live births and account for 50-60% of SNHL.

Hereditary hearing loss may present at birth or onset during childhood. It may also be syndromic (1/3) or non-syndromic (2/3). Most cases (80%) are inherited have an autosomal recessive inheritance pattern although autosomal dominant (15%), X-linked (2%) or mitochondrial (1%). Autosomal recessive syndromes which effect hearing include Usher, Pendred, Alport and Jarvell-Lange-Neilsen syndromes. Autosomal dominant syndromes include Waardenburg, Alport and Neurofibromatosis (NF1 & NF2). X-linked disorders include Alport and Hunter syndromes. Non-syndromic inherited disorders include mutations in the GJB2 and GJB6 genes at 13q12.11 which code for connexin 26 and mutations in STRC (15q15.3) which codes for stereocilin.

Previously, when investigating the cause of congenital hearing loss, negative results for GJB2 and GJB6 gene mutations alone resulted in many cases for which a cause could not be determined. Next-generation sequencing (NGS) technology is now used to test for a large number of genes simultaneously which are associated with hearing loss. Although individual panel components may vary based on the laboratory performing and population testing, most common genes tested are as follow: USH2A, GJB2, GJB6, SLC6, 6A4, KCNQ4, TECTA, MYO6, COCH, SLC26A4, MYO7A, CDH23, MYO6, OTOF, STRC, MIR96, ALMS, WFS1, WFS2.

  • Useful in investigating the cause of hereditary or congenital hearing loss
  • Useful in prenatal screening and family members with a familial history of hearing loss

A positive result indicates the presence of mutations or variants in the targeted gene(s).

A negative result indicates the absence of mutations or variants in the targeted gene(s), and is sufficient to rule out the genetics as a cause of congenital hearing loss.

Negative (No mutations or variants detected in the targeted genes)

Next-generation sequencing (NGS), multiplex ligation-dependent probe amplification (MLPA), Sanger sequencing.

Whole blood (EDTA/ ACD).

Stability

  • Ambient: 3-5 days
  • Refrigerated: 7-14 days
  • Frozen: unstable
Supportive clinical tests, CMV IgG/ IgM, ToRCH IgG/ IgM, fibrinogen, vitamin B12.
1-3 weeks.
Please log in to view content.
Create an account to get a 30-day free trial.
Login
Please log in to view content.
Create an account to get a 30-day free trial.
Login
Please log in to view content.
Create an account to get a 30-day free trial.
Login